RecruitingPhase 2NCT04797286

Sildenafil for Early Pulmonary Vascular Disease in Scleroderma

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Johns Hopkins University
Principal Investigator
Stephen Mathai, MD
Johns Hopkins University
Intervention
Sildenafil(drug)
Enrollment
30 enrolled
Eligibility
18 years · All sexes
Timeline
20212026

Study locations (2)

Collaborators

Louisiana State University Health Sciences Center in New Orleans · United States Department of Defense

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04797286 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis

← Back to all trials